K Tanaka
Vrije Universiteit Brussel
11 Papers
17 Citations
K Tanaka is an academic researcher from Vrije Universiteit Brussel. The author has contributed to research in topics: Fractional flow reserve & Coronary artery disease. The author has an hindex of 2, co-authored 5 publications.
Chat about Author
Papers
How to monitor cardiac toxicity of chemotherapy: time is muscle!
Dirk Kerkhove,Christel Fontaine,S. Droogmans,J De Greve,K Tanaka,Nico Van de Veire,Guy Van Camp +6 more
TL;DR: Left ventricular ejection fraction (LVEF) was chosen as the parameter for monitoring/identifying cardiotoxicity in clinical practice with proven impact on prognosis, but its limitations have been well established over the last 10 years.
16
An unique case of “Atypical Ebstein’s Anomaly” with only isolated displacement of the inferior tricuspid leaflet
TL;DR: This is the first reported case of an isolated displacement of the inferior tricuspid valve leaflet in Ebstein’s anomaly, and it is concluded that this represents a not previously described form of Ebstein's anomaly in which the septal and anterior leaflets were not displaced.
Reduced iodine dose in coronary CT angiography by combining low tube voltage acquisition with iterative reconstruction
T van Cauteren,Nico Buls,K Tanaka,D Verdries,G. Van Gompel,Koenraad Nieboer,Inneke Willekens,J. De Mey +7 more
- 24 Oct 2013
TL;DR: Poster: "ESCR 2013 / 441 / Reduced iodine dose in coronary CT angiography by combining low tube voltage acquisition with iterative reconstruction" by: "T. Van Cauteren1, N. Van Gompel2, K. Nieboer2, I. Willekens1, J. de Mey2; 1Brussel/BE, 2Brussels/BE"
1
The single right coronary artery.
TL;DR: An asymptomatic obese 60-year-old man with an increased cardiovascular risk profile (arterial hypertension and hypercholesterolemia) was checked prior to hip surgery and found the absence of a left coronary ostium and a single RCA with two large right ventricular branches continuing to the left coronary artery (LCA).
Epicardial adipose tissue thickness in COVID-19 hospitalized patients: a tool for risk stratification
M. Luchian,A. Motoc,Stijn Lochy,Dries Belsack,Sven Boeckstaens,Jolien Geers,K Tanaka,E Scheirlynck,Johan De Mey,S. Allard,Julien Magne,Bram Roosens,Caroline Weytjens,Bernard Cosyns,Steven Droogmans +14 more
TL;DR: Although no independent association between RV-EAT and in-hospital mortality was found, RV- EAT thickness may serve as surrogate marker of severity, before the rise of inflammatory biomarkers and may reflect inflammation changes within the myocardium in COVID-19.